Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Net Income (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Net Income came in at $260.0 million in Q2 2026, up 103.12% year-over-year from $128.0 million in Q2 2025, and up 118.17% quarter-over-quarter from -$1.4 billion in Q1 2026.

Analysis

Bausch Health Companies (BHC) Net Income (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Net Income across 18 years of filings, most recently posting $260.0 million for Q2 2026.

  • In Q2 2026, Net Income rose 103.12% year-over-year to $260.0 million; the TTM figure through Jun 2026 stood at -$1.1 billion (down 2377.08% YoY), while the FY2025 annual figure was $120.0 million, up 266.67% from the prior year.
  • Net Income came in at $260.0 million for Q2 2026 at Bausch Health Companies, up from -$1.4 billion in the prior quarter.
  • In the past five years, Net Income ranged from a high of $403.0 million in Q3 2022 to a low of -$1.4 billion in Q1 2026.
  • Average Net Income over 5 years is -$108.1 million, with a median of -$71.5 million recorded in 2022.
  • Year-over-year, Net Income jumped 12900.0% in 2025 and sank 1563.95% in 2026.
  • Over 5 years, Net Income stood at -$410.0 million in 2022, then soared by 88.54% to -$47.0 million in 2023, then jumped by 308.51% to $98.0 million in 2024, then tumbled by 205.1% to -$103.0 million in 2025, then soared by 352.43% to $260.0 million in 2026.
  • Per Business Quant data, the three most recent Net Income figures were $260.0 million in Q2 2026, -$1.4 billion in Q1 2026, and -$103.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -576.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -118.80 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 45.93 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 69.61 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 260.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -66.70 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 24.70 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 30.35 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 1.97 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 260.00 Mn
Mar 31, 2026 -1.43 Bn
Dec 31, 2025 -103.00 Mn
Sep 30, 2025 181.00 Mn
Jun 30, 2025 128.00 Mn
Mar 31, 2025 -86.00 Mn
Dec 31, 2024 98.00 Mn
Sep 30, 2024 -92.00 Mn
Jun 30, 2024 -1.00 Mn
Mar 31, 2024 -77.00 Mn
Dec 31, 2023 -47.00 Mn
Sep 30, 2023 -382.00 Mn
Jun 30, 2023 27.00 Mn
Mar 31, 2023 -209.00 Mn
Dec 31, 2022 -410.00 Mn
Sep 30, 2022 403.00 Mn
Jun 30, 2022 -139.00 Mn
Mar 31, 2022 -66.00 Mn
Dec 31, 2021 72.00 Mn
Sep 30, 2021 191.00 Mn